Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The SIN3 transcription regulator homolog A pseudogene (ENSG00000270322) is a nonfunctional genomic region highly homologous to the functional SIN3A gene, which encodes a transcriptional regulatory protein involved in chromatin remodeling and gene repression[2][7]. As a pseudogene, ENSG00000270322 does not produce a functional protein product and likely arose from duplication or retrotransposition events followed by gene-disabling mutations[2][4][6]. Pseudogenes such as this one are sometimes transcribed but do not have well-established biological functions; in rare cases, their transcripts may regulate gene expression or serve as evolutionary markers, but there is no evidence that ENSG00000270322 is involved in any therapeutic mechanism, disease pathway, or drug interaction. If you are seeking information on the functional SIN3A protein (Sin3A), note that this is a distinct entity, encoded by the functional SIN3A gene (not the pseudogene)[7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SIN3 transcription regulator homolog A pseudogene.